| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |